Foundation review: The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platformSHUKLA, Sunita J; RUILI HUANG; AUSTIN, Christopher P et al.Drug discovery today. 2010, Vol 15, Num 23-24, pp 997-1007, issn 1359-6446, 11 p.Article

Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosisSHUKLA, Sunita J; SHIWEI DUAN; BADNER, Judith A et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 3, pp 253-262, issn 1744-6872, 10 p.Article

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical centerWARREN, David K; SHUKLA, Sunita J; OLSEN, Margaret A et al.Critical care medicine. 2003, Vol 31, Num 5, pp 1312-1317, issn 0090-3493, 6 p.Article

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approachHUANG, R. Stephanie; SHIWEI DUAN; SHUKLA, Sunita J et al.American journal of human genetics. 2007, Vol 81, Num 3, pp 427-437, issn 0002-9297, 11 p.Article

Identification of genomic regions contributing to etoposide-induced cytotoxicityBLEIBEL, Wasim K; DUAN, Shiwei; HUANG, R. Stephanie et al.Human genetics. 2009, Vol 125, Num 2, pp 173-180, issn 0340-6717, 8 p.Article

Profiling Environmental Chemicals for Activity in the Antioxidant Response Element Signaling Pathway Using a High Throughput Screening ApproachSHUKLA, Sunita J; RUILI HUANG; SIMMONS, Steven O et al.Environmental health perspectives. 2012, Vol 120, Num 8, pp 1150-1156, issn 0091-6765, 7 p.Article

Identification of Clinically Used Drugs That Activate Pregnane X ReceptorsSHUKLA, Sunita J; SAKAMURU, Srilatha; RUILI HUANG et al.Drug metabolism and disposition. 2011, Vol 39, Num 1, pp 151-159, issn 0090-9556, 9 p.Article

Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of actionMILLER, Susanne C; RUILI HUANG; SAKAMURU, Srilatha et al.Biochemical pharmacology. 2010, Vol 79, Num 9, pp 1272-1280, issn 0006-2952, 9 p.Article

The Werner's syndrome 4330T>C (Cysl367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compoundsINNOCENTI, Federico; MIRKOV, Snezana; DOLAN, M. Eileen et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 5, pp 881-887, issn 0344-5704, 7 p.Article

Mapping genes that contribute to daunorubicin-induced cytotoxicitySHIWEI DUAN; BLEIBEL, Wasim K; HUANG, Rong Stephanie et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5425-5433, issn 0008-5472, 9 p.Article